Gadoteridol (INN) is a gadolinium-based MRI contrast agent, used particularly in the imaging of the central nervous system.

It is sold under the brand name ProHance.

[3] Gadoteridol was first approved for use in the United States in 1992.

This article about magnetic resonance imaging is a stub.

You can help Wikipedia by expanding it.This pharmacology-related article is a stub.